Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy

被引:3
|
作者
Rao, Anirudh [1 ,2 ]
Singh, Manavotam [3 ]
Maini, Mansi [1 ]
Anderson, Kelley M. M. [4 ]
Crowell, Nancy A. A. [4 ]
Henderson, Paul R. R. [1 ]
Gholami, Sherry S. S. [1 ]
Sheikh, Farooq H. H. [1 ,3 ]
Najjar, Samer S. S. [3 ]
Groninger, Hunter [1 ,2 ]
机构
[1] Georgetown Univ, Sch Med, Dept Med, Washington, DC 20007 USA
[2] MedStar Washington Hosp Ctr, Dept Med, Sect Palliat Med, Washington, DC 20010 USA
[3] MedStar Heart & Vasc Inst, MedStar Washington Hosp Ctr, Washington, DC USA
[4] Georgetown Univ, Sch Nursing & Hlth Studies, Washington, DC USA
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词
inotropes; Stage D heart failure; palliative care; LVAD; heart transplant; HEART-FAILURE; FRAILTY; GUIDELINES; CRITERIA; SOCIETY;
D O I
10.3389/fcvm.2022.918146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMany patients with advanced heart failure (HF) are administered chronic intravenous inotropic support (CIIS) as bridge to surgical therapy; some ultimately never receive surgery. We aimed to describe reasons patients "crossover" from CIIS as bridge therapy to palliative therapy, and compare end-of-life outcomes to patients initiated on CIIS as palliative therapy. MethodsSingle-institution, retrospective cohort study of patients on CIIS as bridge or palliative therapy between 2010 and 2016; data obtained through review of health records and multi-disciplinary selection meeting minutes, was analyzed using descriptive and inferential statistics. ResultsOf 246 patients discharged on CIIS as bridge therapy, 37 (16%) (male n = 28, 76%; African American n = 22, 60%) ultimately never received surgery. 67 matched patients on CIIS as palliative therapy were included for analysis (male n = 47, 70%; African American n = 47, 70%). The most common reasons for "crossover" from CIIS as bridge therapy to palliative therapy were frailty (n = 10, 27%), cardiac arrest (n = 5, 13.5%), and progressive non-cardiac illnesses (n = 6, 16.2%). A similar percentage of patients in the bridge (n = 28, 76%) and palliative (n = 48, 72%) groups died outside the hospital (P=0.66); however, fewer bridge patients received hospice care compared to the palliative group (35% vs 69%, P < 0.001). Comparing patients who died in the hospital, bridge patients (n = 9; 100%) were more likely to die in the intensive care unit than palliative patients (n = 8; 42%) (P < 0.001). ConclusionPatients on CIIS as bridge therapy who do not ultimately receive surgical therapy "crossover" to palliative intention due to frailty, or development of or identification of serious illnesses. Nevertheless, these "bridge to nowhere" patients are less likely to receive palliative care or hospice and more likely to die in the intensive care unit than patients on CIIS as palliative therapy.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] NOT ALL PATIENTS ON CHRONIC INTRAVENOUS INOTROPIC SUPPORT AS "BRIDGE THERAPY" RECEIVE SURGICAL THERAPY FOR ADVANCED HEART FAILURE
    Singh, Manavotam
    Maini, Mansi
    Rao, Anirudh
    Groninger, Hunter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 747 - 747
  • [2] Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Patients With Advanced Heart Failure: A Single-Center Experience
    Rao, Anirudh
    Anderson, Kelley M.
    Mohammed, Selma
    Hofmeyer, Mark
    Gholami, Sherry S.
    Sheikh, Farooq H.
    Rodrigo, Maria E.
    Crowell, Nancy A.
    Javed, Hasan
    Gupta, Shantal
    Hajouli, Said
    Stewart, Diana E.
    Hamad, Ahmad
    Najjar, Samer S.
    Groninger, Hunter
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (09) : 974 - 980
  • [3] Palliative Care for Patients on Continuous Intravenous Inotropic Support as "Bridge Therapy" Who Never Receive Surgical Therapy for Advanced Heart Failure
    Rao, Anirudh
    Henderson, Paul
    Singh, Manavotam
    Groninger, Hunter
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2022, 63 (05) : 935 - 935
  • [4] Chronic Intravenous Inotropic Support As Bridge To Surgical Therapies In Patients With Sarcoidosis-related Cardiomyopathy
    Fajardo, Johana
    Singh, Manavotam
    Hayat, Fatima
    Banerjee, Avantika
    Afari-Armah, Nana
    Kadakkal, Ajay
    Pillarisetty, Anjani
    Zaghlol, Raja
    Rao, Anirudh
    Najjar, Samer
    Sheikh, Farooq
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 549 - 549
  • [5] Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study
    Lin, Chuwen
    Tan, Miaoqin
    Wang, Dongmei
    Gu, Chunping
    Wu, Yongming
    Wang, Shengnan
    PHARMACOLOGY, 2023, 108 (06) : 540 - 549
  • [6] Immunosuppressive Therapy in Patients with Aplastic Anemia: A Single-Center Retrospective Study
    Jalaeikhoo, Hasan
    Khajeh-Mehrizi, Ahmad
    PLOS ONE, 2015, 10 (05):
  • [7] Efficacy of Intravenous Immunoglobulin Therapy for Patients With Sepsis and Low Immunoglobulin G Levels: A Single-Center Retrospective Study
    Akatsuka, Masayuki
    Masuda, Yoshiki
    Tatsumi, Hiroomi
    Sonoda, Tomoko
    CLINICAL THERAPEUTICS, 2022, 44 (02) : 295 - 303
  • [8] A single-center retrospective study evaluating the efficacy of intravenous methylprednisolone pulse therapy for 113 patients with alopecia areata
    Chen, Y.
    Huang, H.
    Chen, Y.
    Lan, C. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S86 - S86
  • [9] Clindamycin Mono-Therapy of Hidradenitis Suppurativa Patients: A Single-Center Retrospective Study
    An, Ji Hae
    Moon, Su Jin
    Shin, Jung U.
    Kim, Dong Hyun
    Yoon, Moon Soo
    Lee, Hee Jung
    ANNALS OF DERMATOLOGY, 2021, 33 (06) : 515 - 521
  • [10] FLAG-IDA regimen as bridge therapy to allotransplant in refractory/relapsed aml patients: a single-center experience
    Pasciolla, C.
    Delia, M.
    Pastore, D.
    Carluccio, P.
    Ricco, A.
    Rossi, A. Russo
    Mestice, A.
    Albano, F.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S395 - S395